A Comparative Study of Selatogrel (ACT-246475) Formulations in Healthy Subjects

NCT04557280 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Viatris Innovation GmbH